Celltrion Symposium:
Expansion of treatment
Options in RA
Supported by Celltrion

12:20 – 13:20 | Industry Symposium: Expansion of treatment Options in RA Supported by Celltrion |
Hall A |
Chairperson | Wen-Chan Tsai, Taiwan | |
12:20 – 12:25 | Welcome and Introduction Wen-Chan Tsai, Taiwan |
|
12:25 – 12:40 | The truth of biosimilar against clinicians’ concern Tore K. Kvien, Norway |
|
12:40 – 12:55 | Future of biosimilar infliximab and global status Tore K. Kvien, Norway |
|
12:55 – 13:10 | Compelling clinical evidence from real world data Aileen Agbanlog, Philippines |
|
13:10 – 13:20 | Panel Discussion |